| 2024 |
| 08/30 | 6,101 | 6,142 | 6,085 | 6,119 | +0.1% | 1,207,900 | 1兆8146億 | +4.87% |
| 08/29 | 6,118 | 6,146 | 6,063 | 6,113 | -0.08% | 909,700 | 1兆8129億 | +4.42% |
| 08/28 | 6,053 | 6,124 | 6,008 | 6,118 | +1.07% | 838,500 | 1兆8143億 | +4.21% |
| 08/27 | 6,001 | 6,072 | 5,976 | 6,053 | +0.48% | 877,500 | 1兆7951億 | +2.77% |
| 08/26 | 6,107 | 6,110 | 5,990 | 6,024 | -2.32% | 1,084,500 | 1兆7865億 | +1.93% |
| 08/23 | 6,219 | 6,271 | 6,118 | 6,167 | -0.26% | 1,144,900 | 1兆8289億 | +3.93% |
| 08/22 | （IR情報）18:05 レケンビ(レカネマブ)、英国(北アイルランドを除く)において、早期アルツハイマー病治療剤として承認を取得 |
| 08/22 | 5,952 | 6,237 | 5,952 | 6,183 | +4.14% | 2,095,800 | 1兆8336億 | +3.83% |
| 08/21 | 5,910 | 6,026 | 5,907 | 5,937 | +0.46% | 1,093,000 | 1兆7607億 | -0.6% |
| 08/20 | 5,921 | 5,957 | 5,875 | 5,910 | +0.54% | 1,067,400 | 1兆7527億 | -1.45% |
| 08/19 | 6,013 | 6,034 | 5,857 | 5,878 | -2.03% | 1,282,300 | 1兆7432億 | -2.67% |
| 08/16 | 5,890 | 6,000 | 5,877 | 6,000 | +2.85% | 1,208,400 | 1兆7794億 | -1.33% |
| 08/15 | 5,764 | 5,836 | 5,750 | 5,834 | +1.3% | 950,000 | 1兆7301億 | -4.47% |
| 08/14 | （自社株買い）取締役会(2024年5月15日)での決議状況(取得期間2024年5月16日～2024年11月15日) |
| 08/14 | 5,740 | 5,768 | 5,676 | 5,759 | +1.48% | 1,165,300 | 1兆7079億 | -6.17% |
| 08/13 | 5,491 | 5,675 | 5,491 | 5,675 | +1.89% | 1,337,100 | 1兆6830億 | -7.98% |
| 08/09 | 5,523 | 5,631 | 5,469 | 5,570 | +1.07% | 1,571,700 | 1兆6518億 | -10.16% |
| 08/08 | 5,460 | 5,570 | 5,392 | 5,511 | -0.54% | 1,255,900 | 1兆6343億 | -11.57% |
| 08/07 | 5,189 | 5,602 | 5,180 | 5,541 | +5.6% | 1,843,200 | 1兆6432億 | -11.68% |
| 08/06 | 5,167 | 5,264 | 5,017 | 5,247 | +4.75% | 3,003,000 | 1兆5560億 | -16.94% |
| 08/05 | 5,358 | 5,441 | 4,986 | 5,009 | -8.48% | 3,093,700 | 1兆4855億 | -21.42% |
| 08/02 | （IR情報）12:30 2024年度第1四半期決算説明会資料 |
| 08/02 | （IR情報）12:30 2024年度(2025年3月期)第1四半期決算参考資料 |
| 08/02 | （IR情報）12:30 2025年3月期第1四半期決算短信〔IFRS〕(連結) |
| 08/02 | 5,620 | 5,631 | 5,457 | 5,473 | -4.32% | 3,592,900 | 1兆6231億 | -14.99% |
| 08/01 | （IR情報）19:45 抗アミロイドβプロトフィブリル抗体「レケンビ」の売上収益(速報)について |
| 08/01 | （IR情報）11:30 自己株式の取得状況に関するお知らせ |
| 08/01 | 5,840 | 5,840 | 5,695 | 5,720 | -0.69% | 2,115,900 | 1兆6963億 | -11.78% |
| 07/31 | 5,807 | 5,817 | 5,685 | 5,760 | -1.87% | 3,187,500 | 1兆7082億 | -11.66% |
| 07/30 | 5,727 | 5,871 | 5,705 | 5,870 | +1.77% | 2,862,500 | 1兆7408億 | -10.45% |
| 07/29 | 5,900 | 5,963 | 5,701 | 5,768 | -12.98% | 6,801,100 | 1兆7105億 | -12.34% |
| 07/26 | （IR情報）20:15 EUにおけるレカネマブの承認審査状況について |
| 07/26 | 6,652 | 6,763 | 6,618 | 6,628 | +0.44% | 1,382,900 | 1兆9656億 | +0.36% |
| 07/25 | 6,586 | 6,648 | 6,562 | 6,599 | +0.96% | 1,426,400 | 1兆9570億 | +0.14% |
| 07/24 | 6,556 | 6,626 | 6,512 | 6,536 | -0.76% | 816,700 | 1兆9383億 | -0.67% |
| 07/23 | 6,528 | 6,598 | 6,525 | 6,586 | +0.17% | 664,500 | 1兆9531億 | +0.24% |
| 07/22 | 6,600 | 6,610 | 6,504 | 6,575 | -0.44% | 881,300 | 1兆9499億 | +0.2% |
| 07/19 | 6,699 | 6,701 | 6,561 | 6,604 | -1.42% | 1,253,300 | 1兆9585億 | +0.84% |
| 07/18 | 6,585 | 6,792 | 6,571 | 6,699 | +1.01% | 1,245,200 | 1兆9867億 | +2.42% |
| 07/17 | 6,549 | 6,672 | 6,540 | 6,632 | +1.25% | 1,427,400 | 1兆9668億 | +1.45% |
| 07/16 | 6,800 | 6,805 | 6,550 | 6,550 | -5.86% | 2,335,600 | 1兆9425億 | +0.2% |
| 07/12 | 6,868 | 6,958 | 6,848 | 6,958 | +0.46% | 1,980,900 | 2兆635億 | +6.23% |
| 07/11 | 6,700 | 6,935 | 6,700 | 6,926 | +4.4% | 1,787,800 | 2兆540億 | +5.85% |
| 07/10 | （自社株買い）取締役会(2024年5月15日)での決議状況(取得期間2024年5月16日～2024年11月15日) |
| 07/10 | 6,610 | 6,634 | 6,556 | 6,634 | +0.32% | 845,500 | 1兆9674億 | +1.42% |
| 07/09 | 6,511 | 6,645 | 6,500 | 6,613 | +1.71% | 1,248,400 | 1兆9611億 | +0.82% |
| 07/08 | 6,485 | 6,539 | 6,476 | 6,502 | +0.37% | 781,300 | 1兆9282億 | -1.08% |
| 07/05 | 6,370 | 6,483 | 6,368 | 6,478 | +1.65% | 932,900 | 1兆9211億 | -1.62% |
| 07/05 | （空売り報告）GOLDMAN SACHS INTERNATIONAL 1,452,346株（0.48%）-0.02%義務消失 |
| 07/04 | 6,370 | 6,473 | 6,333 | 6,373 | -2.85% | 2,118,800 | 1兆8900億 | -3.38% |
| 07/04 | （空売り報告）GOLDMAN SACHS INTERNATIONAL 1,507,504株（0.5%）再IN |
| 07/03 | 6,571 | 6,658 | 6,495 | 6,560 | -1% | 1,834,500 | 1兆9454億 | -0.68% |
| 07/02 | 6,660 | 6,680 | 6,524 | 6,626 | -0.81% | 1,464,500 | 1兆9650億 | +0.26% |
| 07/01 | （IR情報）15:30 抗体薬物複合体farletuzumab ecteribulin(FZEC)に関して、エーザイ単独でのグローバル開発・商業化に移行 |
| 07/01 | （IR情報）11:30 自己株式の取得状況に関するお知らせ |
| 07/01 | 6,640 | 6,690 | 6,587 | 6,680 | +1.33% | 947,800 | 1兆9810億 | +1.01% |
| 06/28 | 6,630 | 6,680 | 6,581 | 6,592 | -0.56% | 1,069,700 | 1兆9549億 | -0.38% |
| 06/27 | （IR情報）15:00 投資単位の引下げに関する考え方および方針等について |
| 06/27 | 6,555 | 6,646 | 6,535 | 6,629 | +0.03% | 970,000 | 1兆9659億 | +0.08% |
| 06/26 | 6,697 | 6,736 | 6,619 | 6,627 | -0.08% | 1,477,500 | 1兆9653億 | +0.05% |
| 06/25 | 6,450 | 6,632 | 6,417 | 6,632 | +2.2% | 1,223,700 | 1兆9668億 | +0.14% |
| 06/24 | 6,403 | 6,489 | 6,369 | 6,489 | +2.01% | 808,200 | 1兆9244億 | -2.02% |
| 06/21 | 6,254 | 6,388 | 6,254 | 6,361 | +1.19% | 1,250,800 | 1兆8864億 | -4.06% |
| 06/20 | 6,349 | 6,399 | 6,252 | 6,286 | -0.99% | 850,600 | 1兆8642億 | -5.43% |
| 06/19 | 6,267 | 6,359 | 6,263 | 6,349 | +0.86% | 909,600 | 1兆8829億 | -4.81% |
| 06/18 | 6,356 | 6,389 | 6,267 | 6,295 | -1.25% | 955,500 | 1兆8668億 | -5.92% |
| 06/17 | 6,260 | 6,375 | 6,230 | 6,375 | +1.9% | 1,078,200 | 1兆8906億 | -5.04% |
| 06/14 | （IR情報）17:00 エーザイ株式会社役員体制 |
| 06/14 | 6,310 | 6,339 | 6,220 | 6,256 | -2.4% | 2,535,100 | 1兆8553億 | -7.02% |
| 06/13 | 6,590 | 6,616 | 6,341 | 6,410 | -2.63% | 1,660,400 | 1兆9009億 | -5.04% |
| 06/12 | （自社株買い）取締役会(2024年5月15日)での決議状況(取得期間2024年5月16日～2024年11月15日) |
| 06/12 | 6,520 | 6,602 | 6,509 | 6,583 | -0.99% | 1,142,200 | 1兆9523億 | -2.63% |
| 06/11 | 6,665 | 6,705 | 6,527 | 6,649 | -3.25% | 2,969,200 | 1兆9718億 | -1.67% |
| 06/10 | 6,726 | 6,929 | 6,712 | 6,872 | +1.54% | 893,600 | 2兆380億 | +1.66% |
| 06/07 | 6,811 | 6,837 | 6,759 | 6,768 | -1.66% | 1,146,200 | 2兆71億 | +0.31% |
| 06/06 | 7,060 | 7,096 | 6,848 | 6,882 | -2.8% | 1,641,700 | 2兆409億 | +2.14% |
| 06/05 | 7,000 | 7,110 | 6,998 | 7,080 | +1.65% | 2,006,600 | 2兆996億 | +5.31% |
| 06/04 | 6,767 | 6,965 | 6,767 | 6,965 | +2.14% | 1,438,100 | 2兆655億 | +4.13% |
| 06/03 | （IR情報）11:30 自己株式の取得状況に関するお知らせ |
| 06/03 | 6,790 | 6,825 | 6,733 | 6,819 | +0.98% | 910,300 | 2兆222億 | +2.37% |
| 05/31 | 6,680 | 6,762 | 6,656 | 6,753 | +2.71% | 1,967,300 | 2兆27億 | +1.82% |
| 05/30 | 6,598 | 6,628 | 6,432 | 6,575 | -1.37% | 1,299,700 | 1兆9499億 | -0.45% |
| 05/29 | 6,707 | 6,750 | 6,665 | 6,666 | -1.02% | 879,300 | 1兆9769億 | +1.21% |
| 05/28 | 6,800 | 6,830 | 6,710 | 6,735 | -0.68% | 860,300 | 1兆9973億 | +2.75% |
| 05/27 | 6,811 | 6,825 | 6,686 | 6,781 | +0.25% | 875,500 | 2兆110億 | +4.02% |
| 05/24 | 6,649 | 6,764 | 6,624 | 6,764 | +1.87% | 1,129,600 | 2兆59億 | +4.32% |
| 05/23 | 6,609 | 6,657 | 6,530 | 6,640 | +0.71% | 1,130,200 | 1兆9692億 | +2.87% |
| 05/22 | 6,639 | 6,707 | 6,575 | 6,593 | -0.69% | 933,000 | 1兆9552億 | +2.53% |
| 05/21 | 6,630 | 6,669 | 6,540 | 6,639 | -0.24% | 1,202,100 | 1兆9689億 | +3.6% |
| 05/20 | 6,693 | 6,712 | 6,620 | 6,655 | -1.83% | 1,468,900 | 1兆9736億 | +4.29% |
| 05/17 | 6,793 | 6,801 | 6,646 | 6,779 | -1.27% | 1,426,000 | 2兆104億 | +6.66% |
| 05/16 | 6,940 | 7,077 | 6,828 | 6,866 | +0.03% | 2,516,400 | 2兆362億 | +8.47% |
| 05/15 | （IR情報）12:30 2023年度決算説明会資料 |
| 05/15 | （IR情報）12:30 自己株式の取得に係る事項の決定および自己株式の消却に関するお知らせ |
| 05/15 | （IR情報）12:30 取締役候補者および執行役候補者の選任に関するお知らせ |
| 05/15 | （IR情報）12:30 2023年度(2024年3月期)通期決算参考資料 |
| 05/15 | （IR情報）12:30 代表執行役の異動に関するお知らせ |
| 05/15 | （IR情報）12:30 2024年3月期決算短信〔IFRS〕(連結) |
| 05/15 | 6,850 | 6,974 | 6,684 | 6,864 | +0.25% | 3,523,300 | 2兆356億 | +8.95% |
| 05/14 | 6,793 | 6,886 | 6,749 | 6,847 | +1.23% | 1,234,200 | 2兆305億 | +9.2% |
| 05/13 | 6,775 | 6,786 | 6,699 | 6,764 | -0.43% | 985,000 | 2兆59億 | +8.45% |
| 05/10 | 6,730 | 6,807 | 6,703 | 6,793 | +1.55% | 1,269,100 | 2兆145億 | +9.48% |
| 05/09 | 6,640 | 6,761 | 6,640 | 6,689 | +1.2% | 1,424,900 | 1兆9837億 | +8.31% |
| 05/08 | 6,557 | 6,648 | 6,525 | 6,610 | +0.23% | 1,097,400 | 1兆9603億 | +7.44% |
| 05/07 | 6,600 | 6,621 | 6,515 | 6,595 | +0.76% | 1,653,700 | 1兆9558億 | +7.48% |
| 05/02 | 6,540 | 6,554 | 6,472 | 6,545 | -0.06% | 995,400 | 1兆9410億 | +6.91% |
| 05/01 | 6,472 | 6,607 | 6,411 | 6,549 | +0.72% | 1,404,000 | 1兆9422億 | +7.08% |
| 04/30 | 6,309 | 6,515 | 6,267 | 6,502 | +4.2% | 2,085,800 | 1兆9282億 | +6.45% |
| 04/26 | 6,200 | 6,248 | 6,136 | 6,240 | -0.3% | 1,179,200 | 1兆8505億 | +2.3% |
| 04/25 | 6,250 | 6,333 | 6,176 | 6,259 | +2.79% | 2,587,700 | 1兆8562億 | +2.52% |
| 04/24 | 6,117 | 6,173 | 6,047 | 6,089 | -0.02% | 1,168,700 | 1兆8057億 | -0.36% |
| 04/23 | 6,150 | 6,160 | 6,043 | 6,090 | -0.03% | 641,600 | 1兆8060億 | -0.51% |
| 04/22 | 5,969 | 6,098 | 5,923 | 6,092 | +3.24% | 1,002,400 | 1兆8066億 | -0.7% |
| 04/19 | 5,800 | 5,920 | 5,795 | 5,901 | +1.32% | 1,410,700 | 1兆7500億 | -3.96% |
| 04/18 | 5,875 | 5,913 | 5,811 | 5,824 | -1.36% | 1,118,500 | 1兆7272億 | -5.41% |
| 04/17 | 6,037 | 6,040 | 5,901 | 5,904 | -2.45% | 1,041,800 | 1兆7509億 | -4.53% |
| 04/16 | 5,950 | 6,052 | 5,928 | 6,052 | +0.67% | 797,900 | 1兆7948億 | -2.5% |
| 04/15 | 5,971 | 6,026 | 5,928 | 6,012 | -0.48% | 648,000 | 1兆7829億 | -3.34% |
| 04/12 | 6,023 | 6,045 | 5,971 | 6,041 | +1.21% | 776,900 | 1兆7915億 | -3.05% |
| 04/11 | 5,950 | 6,004 | 5,923 | 5,969 | -0.81% | 754,600 | 1兆7702億 | -4.22% |
| 04/10 | 6,106 | 6,130 | 6,018 | 6,018 | -1.83% | 622,900 | 1兆7847億 | -3.51% |
| 04/09 | 6,143 | 6,143 | 6,066 | 6,130 | +0.18% | 765,600 | 1兆8179億 | -1.76% |
| 04/08 | 6,140 | 6,185 | 6,068 | 6,119 | +0.25% | 787,000 | 1兆8146億 | -2.02% |
